Latest Pharmaceutical Manufacturing News
Dyne Testing
Dyne Testing presents instrument for tension measurement
Dyne Testing, an Intertronics brand, presents the Sigma 702 Force Tensiometer from Biolin Scientific, a standalone instrument for precise surface tension and interfacial tension measurement.
14 Mar 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
Antares Vision Group
Antares Vision Group to showcase at INTERPHEX NYC
Antares Vision Group will offer live demonstrations of a high-speed system providing 100% inspection and leak detection for liquid-filled glass containers at INTERPHEX NYC, 1-3rd April in New York.
14 Mar 2025
Syngene
Syngene acquires its first manufacturing facility in the US
Syngene International, a contract research, development, and manufacturing organisation (CRDMO), has announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines.
14 Mar 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
Adragos Pharma
Adragos Pharma completes installation of a liquid filling line
Adragos Pharma has announced the completion of a €4 million project to install and commission an advanced, cGMP-compliant liquid filling line and accompanying cartoning machine at its facility in Leipzig, Germany.
13 Mar 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
BOY ANTHONY Shutterstock
42 Technology demonstrates new AI-powered pharma line clearance solution
42 Technology (42T) has joined forces with industry experts in machine vision, edge AI silicon and software – Balluff, Synaptics and Arcturus Networks – to help develop and demonstrate a breakthrough approach for AI-powered automated line clearance.
13 Mar 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
A9 STUDIO Shutterstock
Rimkus acquires Human Factors Consulting Services
Rimkus Consulting Group has announced the acquisition of Human Factors Consulting Services, Incorporated (“HFCSI”), a highly regarded firm specialising in proactive human factors services and medical device consulting.
12 Mar 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
i-team Global
i-team Global launches battery-powered cleanroom floor cleaning range
i-team Global launches the SAFE-T product family, the "world’s first" battery-powered cleanroom floor cleaning range.
14 Mar 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
ilikeyellow Shutterstock
Icotrokinra results show potential to for treatment in plaque psoriasis
Johnson & Johnson has announced new icotrokinra (JNJ2113) data from its comprehensive Phase 3 clinical programme and the start of the first head-to-head study in plaque psoriasis (Pso) seeking to demonstrate the superiority of an oral pill.
10 Mar 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Sorry, no results.
Shutterstock AI Generator Shutterstock
Lonza CHI establishes Center of Applied Sustainability
Lonza Capsules & Health Ingredients has announced it has established a Center of Applied Sustainability.
11 Mar 2025
Pharma Manufacturing News + Pharmaceutical Sustainability News
petrmalinak Shutterstock
Working together for a sustainable future
Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor so the two companies can work together to develop more efficient, flexible and sustainable cell cultivation processes in the pharmaceutical industries.
18 Feb 2025
Pharma Manufacturing News + Pharmaceutical Sustainability News
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sorry, no results.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00